Fluorodopa F-18: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Fluorodopa F-18. Educational only — not medical advice.
Labeled uses
Fluorodopa F 18 Injection is indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Fluorodopa F 18 PET is an adjunct to other diagnostic evaluations.
Source: FDA labeling via NIH DailyMed (set 37f8c405…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.